Introducing DensityDx

Calcaneal bone density testing is rapidly becoming the leading screening method for diagnosing low bone density and osteoporosis. Unfortunately, current DXA scans which serve as the gold standard for diagnosing low bone density present three major problems to the healthcare system: limited access, high cost, and health risks through patient exposure to radiation.

DensityDx is envisioned as a point-of-care bone density screening instrument. Recent development efforts have resulted in an alpha prototype ready for refinement and testing. Next steps include beta prototype development, clinical trials, production model design/ manufacturing and commercial product launch.

For more information, email us at